Major and minor depression in Parkinson's disease: a neuropsychological investigation

A Costa1, A Peppe, G A Carlesimo

  • 1I.R.C.C.S. Fondazione Santa Lucia, Rome, Italy. a.costa@hsantalucia.it

Insights

Major depression (MD) in Parkinson's disease (PD) patients significantly impacts cognitive functions, unlike minor depression (MiD). These findings suggest a continuum of cognitive decline in PD with increasing depression severity.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Neurology

Background:

  • Idiopathic Parkinson's disease (PD) is frequently associated with depression.
  • Previous research has not clearly differentiated the cognitive effects of major depression (MD) versus minor depression (MiD) in PD patients.

Purpose of the Study:

  • To investigate the distinct relationships between major depression (MD) and minor depression (MiD) and specific neuropsychological deficits in patients with idiopathic Parkinson's disease (PD).

Main Methods:

  • Eighty-three PD patients were assessed using the Structured Clinical Interview for DSM-IV (SCID-I) for MD and MiD diagnosis.
  • Depression severity was measured using the Beck Depression Inventory.
  • Neuropsychological testing included assessments of episodic memory, working memory, executive functions, abstract reasoning, and language abilities.

Main Results:

  • PD patients with MD showed significant impairments in long-term verbal episodic memory, abstract reasoning, and executive functions compared to non-depressed PD patients.
  • PD patients with MiD exhibited cognitive performance levels intermediate to the other groups, without statistically significant differences.
  • The results suggest MD is linked to a specific cognitive profile in PD, potentially involving prefrontal and limbic alterations.

Conclusions:

  • Major depression in Parkinson's disease is associated with a distinct pattern of cognitive impairment.
  • Minor depression and major depression in PD may represent a spectrum of severity, correlating with progressive cognitive deficits.
  • Cognitive deficits in PD patients with MD may stem from alterations in prefrontal and limbic cortical regions.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...